Swiss All Share Index

Swiss All Share Index handeln
18.523,94 PKT -3,19 PKT -0,02 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
28.06.19 Roche overweight JP Morgan Chase & Co.
28.06.19 Nestlé Hold HSBC
27.06.19 Novartis Neutral UBS AG
27.06.19 ABB (Asea Brown Boveri) Sector Perform RBC Capital Markets
26.06.19 Swiss Re Hold Deutsche Bank AG
25.06.19 Nestlé buy Kepler Cheuvreux
25.06.19 Novartis Conviction Buy List Goldman Sachs Group Inc.
25.06.19 Nestlé overweight JP Morgan Chase & Co.
24.06.19 Swiss Re overweight JP Morgan Chase & Co.
24.06.19 Nestlé buy Deutsche Bank AG
24.06.19 UBS Sector Perform RBC Capital Markets
20.06.19 Swiss Re Sell UBS AG
20.06.19 Roche buy Deutsche Bank AG
20.06.19 Zurich Insurance overweight JP Morgan Chase & Co.
19.06.19 UBS buy Deutsche Bank AG
19.06.19 UBS Hold Deutsche Bank AG
17.06.19 Givaudan Hold Deutsche Bank AG
17.06.19 ABB (Asea Brown Boveri) Underweight JP Morgan Chase & Co.
14.06.19 Alcon Neutral BTIG Research
14.06.19 ABB (Asea Brown Boveri) Reduce Oddo BHF
13.06.19 Zurich Insurance Neutral Oddo BHF
12.06.19 Novartis Conviction Buy Goldman Sachs Group Inc.
12.06.19 Roche buy Goldman Sachs Group Inc.
12.06.19 UBS Neutral JP Morgan Chase & Co.
12.06.19 UBS overweight JP Morgan Chase & Co.
11.06.19 Nestlé overweight JP Morgan Chase & Co.
11.06.19 Zurich Insurance Neutral JP Morgan Chase & Co.
11.06.19 Holcim Neutral UBS AG
05.06.19 Zurich Insurance buy Goldman Sachs Group Inc.
05.06.19 Holcim Hold Kepler Cheuvreux
05.06.19 Roche overweight JP Morgan Chase & Co.
04.06.19 Novartis Underweight JP Morgan Chase & Co.
04.06.19 Novartis Neutral UBS AG
03.06.19 Zurich Insurance Hold HSBC
03.06.19 Swiss Re buy HSBC
03.06.19 Roche overweight JP Morgan Chase & Co.
31.05.19 ABB (Asea Brown Boveri) Underweight JP Morgan Chase & Co.
30.05.19 Novartis Underweight Morgan Stanley
29.05.19 Roche overweight JP Morgan Chase & Co.
29.05.19 Novartis Underweight JP Morgan Chase & Co.